Skip to main content
logo
Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.5025
-0.0306 (-5.74%)
At close: Dec 2, 2025

Biotricity Revenue

Biotricity had revenue of $3.89M in the quarter ending September 30, 2025, with 18.95% growth. This brings the company's revenue in the last twelve months to $15.08M, up 19.51% year-over-year. In the fiscal year ending March 31, 2025, Biotricity had annual revenue of $13.79M with 14.32% growth.

Revenue (ttm)
15.08M
Revenue Growth
+19.51%
P/S Ratio
0.99
Revenue / Employee
327.86K
Employees
46
Market Cap
14.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202513.79M1.73M14.32%
Mar 31, 202412.06M2.42M25.15%
Mar 31, 20239.64M1.99M26.00%
Mar 31, 20227.65M4.27M126.02%
Mar 31, 20213.38M1.97M138.75%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Global Cord Blood196.10M
Elite Pharmaceuticals122.89M
Mid-Atlantic Home Health Network27.00M
Silence Therapeutics25.83M
Northwest Biotherapeutics937.00K
Revenue Rankings

Biotricity News

More News